Previous 10 | Next 10 |
ARDEN HILLS, Minn., July 26, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release i...
IntriCon Corporation (IIN) Q1 2021 Results Conference Call May 10, 2021 05:00 PM ET Company Participants Leigh Salvo - Investor Relations Scott Longval - Chief Executive Officer Ellen Scipta - Chief Financial Officer Conference Call Participants Andrew D'Silva - B. Riley Securities Jon Block ...
IntriCon (IIN): Q1 Non-GAAP EPS of $0.26 beats by $0.26; GAAP EPS of $0.07 beats by $0.07.Revenue of $31.77M (+47.8% Y/Y) beats by $5.02M.Press Release For further details see: IntriCon EPS beats by $0.26, beats on revenue
ARDEN HILLS, Minn., May 10, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial r...
ARDEN HILLS, Minn., April 26, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release ...
ARDEN HILLS, Minn., March 22, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced the appointment of K...
IntriCon Corporation (IIN) Q4 2020 Earnings Conference Call February 25, 2021 17:00 ET Company Participants Leigh Salvo - Investor Relations Scott Longval - Chief Executive Officer Ellen Scipta - Chief Financial Officer Conference Call Participants Jon Block - Stifel Andrew D’Silva - B...
IntriCon (IIN): Q4 GAAP EPS of $0.12 beats by $0.08.Revenue of $30.3M (+9.4% Y/Y) beats by $2.95M.Press Release For further details see: IntriCon EPS beats by $0.08, beats on revenue
ARDEN HILLS, Minn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for...
ARDEN HILLS, Minn., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release i...
News, Short Squeeze, Breakout and More Instantly...
ARDEN HILLS, Minn., May 24, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, toda...
IntriCon Corporation (NASDAQ:IIN) traded today at a new 52-week high of $76.80. Approximately 8.6 million shares have changed hands today, as compared to an average 30-day volume of 199,000 shares. IntriCon Corp is an international company and joint development manufacturer (JDM) of micr...
Check Out These Health Care Stocks In The Stock Market Today Given the current volatility in the market, some investors may be looking to rotate into lower-risk sectors of the stock market . Hence, health care stocks could be worth considering. This is because regardless of the ...